These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

486 related articles for article (PubMed ID: 33132228)

  • 21. Efficacy and Safety of Rivaroxaban Versus Aspirin in Embolic Stroke of Undetermined Source and Carotid Atherosclerosis.
    Ntaios G; Swaminathan B; Berkowitz SD; Gagliardi RJ; Lang W; Siegler JE; Lavados P; Mundl H; Bornstein N; Meseguer E; Amarenco P; Cucchiara B; Camps-Renom P; Makaritsis K; Korompoki E; Papavasileiou V; Marti-Fabregas J; Milionis H; Vemmos K; Connolly SJ; Hart RG;
    Stroke; 2019 Sep; 50(9):2477-2485. PubMed ID: 31401971
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source.
    Hart RG; Sharma M; Mundl H; Kasner SE; Bangdiwala SI; Berkowitz SD; Swaminathan B; Lavados P; Wang Y; Wang Y; Davalos A; Shamalov N; Mikulik R; Cunha L; Lindgren A; Arauz A; Lang W; Czlonkowska A; Eckstein J; Gagliardi RJ; Amarenco P; Ameriso SF; Tatlisumak T; Veltkamp R; Hankey GJ; Toni D; Bereczki D; Uchiyama S; Ntaios G; Yoon BW; Brouns R; Endres M; Muir KW; Bornstein N; Ozturk S; O'Donnell MJ; De Vries Basson MM; Pare G; Pater C; Kirsch B; Sheridan P; Peters G; Weitz JI; Peacock WF; Shoamanesh A; Benavente OR; Joyner C; Themeles E; Connolly SJ;
    N Engl J Med; 2018 Jun; 378(23):2191-2201. PubMed ID: 29766772
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rivaroxaban versus aspirin for secondary prevention of ischaemic stroke in patients with cancer: a subgroup analysis of the NAVIGATE ESUS randomized trial.
    Martinez-Majander N; Ntaios G; Liu YY; Ylikotila P; Joensuu H; Saarinen J; Perera KS; Marti-Fabregas J; Chamorro A; Rudilosso S; Prats-Sanchez L; Berkowitz SD; Mundl H; Themeles E; Tiainen M; Demchuk A; Kasner SE; Hart RG; Tatlisumak T;
    Eur J Neurol; 2020 May; 27(5):841-848. PubMed ID: 32056346
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Branch atheromatous disease diagnosed as embolic stroke of undetermined source: A sub-analysis of NAVIGATE ESUS.
    Uchiyama S; Toyoda K; Kitagawa K; Okada Y; Ameriso S; Mundl H; Berkowitz S; Yamada T; Liu YY; Hart RG;
    Int J Stroke; 2019 Dec; 14(9):915-922. PubMed ID: 31132967
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intracranial and systemic atherosclerosis in the NAVIGATE ESUS trial: Recurrent stroke risk and response to antithrombotic therapy.
    Ameriso SF; Amarenco P; Pearce LA; Perera KS; Ntaios G; Lang W; Bereczki D; Uchiyama S; Kasner SE; Yoon BW; Lavados P; Firstenfeld A; Mikulik R; Povedano GP; Ferrari J; Mundl H; Berkowitz SD; Connolly SJ; Hart RG
    J Stroke Cerebrovasc Dis; 2020 Aug; 29(8):104936. PubMed ID: 32689594
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-Sensitivity Cardiac Troponin T for Risk Stratification in Patients With Embolic Stroke of Undetermined Source.
    Scheitz JF; Pare G; Pearce LA; Mundl H; Peacock WF; Czlonkowska A; Sharma M; Nolte CH; Shoamanesh A; Berkowitz SD; Krahn T; Endres M;
    Stroke; 2020 Aug; 51(8):2386-2394. PubMed ID: 32640945
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Past and future of the ESUS concept].
    Diener HC; Endres M
    Nervenarzt; 2020 Jun; 91(6):511-517. PubMed ID: 32221634
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of dabigatran plasma concentrations and patient characteristics on the frequency of ischemic stroke and major bleeding in atrial fibrillation patients: the RE-LY Trial (Randomized Evaluation of Long-Term Anticoagulation Therapy).
    Reilly PA; Lehr T; Haertter S; Connolly SJ; Yusuf S; Eikelboom JW; Ezekowitz MD; Nehmiz G; Wang S; Wallentin L;
    J Am Coll Cardiol; 2014 Feb; 63(4):321-8. PubMed ID: 24076487
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of Patients with Embolic Strokes of Undetermined Source in the NAVIGATE ESUS Randomized Trial.
    Kasner SE; Lavados P; Sharma M; Wang Y; Wang Y; Dávalos A; Shamalov N; Cunha L; Lindgren A; Mikulik R; Arauz A; Lang W; Czlonkowska A; Eckstein J; Gagliardi R; Amarenco P; Ameriso SF; Tatlisumak T; Veltkamp R; Hankey GJ; Toni DS; Bereczki D; Uchiyama S; Ntaios G; Yoon BW; Brouns R; DeVries Basson MM; Endres M; Muir K; Bornstein N; Ozturk S; O'Donnell M; Mundl H; Pater C; Weitz J; Peacock WF; Swaminathan B; Kirsch B; Berkowitz SD; Peters G; Pare G; Themeles E; Shoamanesh A; Connolly SJ; Hart RG;
    J Stroke Cerebrovasc Dis; 2018 Jun; 27(6):1673-1682. PubMed ID: 29525076
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rivaroxaban versus aspirin on functional and cognitive outcomes after embolic stroke of undetermined source: NAVIGATE ESUS trial.
    Bosch J; Pearce LA; Sharma M; Canavan M; Whiteley WN; Mikulík R; Mundl H; Yusuf S; Hart RG; O'Donnell MJ
    J Stroke Cerebrovasc Dis; 2022 May; 31(5):106404. PubMed ID: 35292423
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potential Embolic Sources and Outcomes in Embolic Stroke of Undetermined Source in the NAVIGATE-ESUS Trial.
    Ntaios G; Pearce LA; Veltkamp R; Sharma M; Kasner SE; Korompoki E; Milionis H; Mundl H; Berkowitz SD; Connolly SJ; Hart RG;
    Stroke; 2020 Jun; 51(6):1797-1804. PubMed ID: 32295509
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anticoagulation and Risk of Stroke Recurrence in Patients with Embolic Stroke of Undetermined Source Having No Potential Source of Embolism.
    Sato N; Matsuo R; Kiyuna F; Nakamura K; Hata J; Wakisaka Y; Ago T; Kamouchi M; Kitazono T;
    Cerebrovasc Dis; 2020; 49(6):601-608. PubMed ID: 33176316
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ticagrelor Versus Aspirin in Acute Embolic Stroke of Undetermined Source.
    Amarenco P; Albers GW; Denison H; Easton JD; Evans SR; Held P; Hill MD; Jonasson J; Kasner SE; Ladenvall P; Minematsu K; Molina CA; Wang Y; Wong KSL; Johnston SC;
    Stroke; 2017 Sep; 48(9):2480-2487. PubMed ID: 28720658
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recurrent Stroke With Rivaroxaban Compared With Aspirin According to Predictors of Atrial Fibrillation: Secondary Analysis of the NAVIGATE ESUS Randomized Clinical Trial.
    Healey JS; Gladstone DJ; Swaminathan B; Eckstein J; Mundl H; Epstein AE; Haeusler KG; Mikulik R; Kasner SE; Toni D; Arauz A; Ntaios G; Hankey GJ; Perera K; Pagola J; Shuaib A; Lutsep H; Yang X; Uchiyama S; Endres M; Coutts SB; Karlinski M; Czlonkowska A; Molina CA; Santo G; Berkowitz SD; Hart RG; Connolly SJ
    JAMA Neurol; 2019 Jul; 76(7):764-773. PubMed ID: 30958508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Review and update of the concept of embolic stroke of undetermined source.
    Diener HC; Easton JD; Hart RG; Kasner S; Kamel H; Ntaios G
    Nat Rev Neurol; 2022 Aug; 18(8):455-465. PubMed ID: 35538232
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Secondary Stroke Prevention in Cryptogenic Stroke and Embolic Stroke of Undetermined Source (ESUS).
    Diener HC; Bernstein R; Hart R
    Curr Neurol Neurosci Rep; 2017 Sep; 17(9):64. PubMed ID: 28707135
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association Between Low-Dose Rivaroxaban With or Without Aspirin and Ischemic Stroke Subtypes: A Secondary Analysis of the COMPASS Trial.
    Perera KS; Ng KKH; Nayar S; Catanese L; Dyal L; Sharma M; Connolly SJ; Yusuf S; Bosch J; Eikelboom JW; Hart RG
    JAMA Neurol; 2020 Jan; 77(1):43-48. PubMed ID: 31524941
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aortic Arch Atherosclerosis in Patients With Embolic Stroke of Undetermined Source: An Exploratory Analysis of the NAVIGATE ESUS Trial.
    Ntaios G; Pearce LA; Meseguer E; Endres M; Amarenco P; Ozturk S; Lang W; Bornstein NM; Molina CA; Pagola J; Mundl H; Berkowitz SD; Liu YY; Sen S; Connolly SJ; Hart RG
    Stroke; 2019 Nov; 50(11):3184-3190. PubMed ID: 31526123
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral anticoagulation versus antiplatelet therapy for secondary stroke prevention in patients with embolic stroke of undetermined source: A systematic review and meta-analysis.
    Hariharan NN; Patel K; Sikder O; Perera KS; Diener HC; Hart RG; Eikelboom JW
    Eur Stroke J; 2022 Jun; 7(2):92-98. PubMed ID: 35647310
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cryptogenic Stroke: Diagnostic Workup and Management.
    Mac Grory B; Flood SP; Apostolidou E; Yaghi S
    Curr Treat Options Cardiovasc Med; 2019 Dec; 21(11):77. PubMed ID: 31792625
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.